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Abstract
The squamous stratified epithelia contain a proliferative
(harboring mitotic activity) and a differentiating compart-
ment. Due to the potential of protein-carbohydrate inter-
actions to regulate cellular activities we introduced a
mammalian lectin to cyto- and histochemical analysis.
We answer the questions of whether and to what extent
this new probe can pinpoint differentiation-dependent
glycosylation changes in sections and in culture of kerati-
nocytes. Material and Methods: Purification and labeling
enabled monitoring of galectin-3 reactivity in frozen sec-
tions of human and pig epidermis and basal cell carcino-
mas as well as in culture of keratinocytes. The staining
pattern of the lectin was correlated with the staining pro-
file of other cell markers including desmosomal proteins,
ß1 integrin, and the proliferation marker Ki-67. The Doli-
chos biflorus agglutinin (DBA) sharing binding reactivity
of galectin-3 to the A type histoblood group epitope was
used for comparison. Results: Both lectins exhibit supra-
basal binding. However, their profiles were not identical,
substantiated by lack of coinhibition. Strong DBA reactiv-
ity was also observed in a limited number of basal layer
cells, namely in cells without the expression of the prolif-
eration marker Ki-67. Cultured mitotic epidermal cells
have no reactivity for DBA. Presence of ligands for this
plant lectin was connected with decreased positivity of
nuclei for Ki-67 and the occurrence of ring-shaped nu-
cleoli, micronucleoli or absence of nucleoli. Considering
colocalization the pattern of galectin-3-binding sites
coincided with the presence of desmosomal proteins
such as desmoplakin-1 and desmoglein but not ß1 inte-
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grin, a potential ligand. Interestingly, studied basal cell
carcinomas expressed no binding sites for galectin-3,
while a limited number of cells were DBA-reactive. Con-
clusion: The expression of galectin-3-binding sites and
also DBA-reactive glycoligands correlates with an in-
creased level of differentiation and/or cessation of prolif-
eration in the examined squamous stratified epithelia.
Further application of tissue lectins for characterizing
ligand expression and its modulation is an important
step to reveal functional relevance.
Copyright © 2002 S. Karger AG, Basel
Introduction
Squamous epithelia such as the epidermis represent an
example of a morphologically and funtionally diversified
tissue. The pool of mitotically active cells is located in the
basal layer of the epithelium. It includes the epidermal
stem cells and their daughter cells, i.e. the transit-amplify-
ing cells with already limited mitotic ability. The other
cell population, the postmitotic differentiating cells, move
laterally and superficially. The functional specialization
of these cells such as formation of desmosomes and kera-
tinization increases in the course of this process [Cotsare-
lis et al., 1999; Kaur and Li, 2000]. Differences between
cells from basal and suprabasal layers with respect to
receptor expression such as integrins and cadherins as
well as display of intermediate filaments (cytokeratins)
have been considered useful for diagnostic purposes
[Watt and Jones, 1993; Hodivala and Watt, 1994; Jensen
and Wheelock, 1996; Kanitakis, 1998]. For example, the
stem cells differ from other cell types of the basal cell layer
in quantity of presence of certain adhesion molecules such
as the ß1 integrin chain [Watt, 1998]. It is noteworthy that
this integrin subunit bearing ß-galactosides and poly-N-
acetyllactosamine extension in its glycan chains is not
only involved in protein-protein interactions. In fact, it
can be a target for the endogenous lectin galectin-3 (Gal-
3), a factor in the terminal differentiation of epithelial
cells by hensin assembly into large aggregates (Ochieng et
al., 1998; André et al., 1999; Hikita et al., 2000]. Thus, in
addition to determinants for protein-protein interaction
reactants in other systems of molecular recognition de-
serve consideration in cyto- and histochemical analysis.
Oligosaccharides and endogenous lectins establish the
ligand-receptor part of information transfer of the sugar
code [Reuter and Gabius, 1999; Gabius, 2000; Solı´s et al.,
2001]. In this report we address the questions if and to
what extent epitopes reactive with an endogenous lectin
in squamous cell epithelia undergo differentiation-depen-
dent changes. So far, classical plant lectin histochemistry
has been the standard method to access glycan expression
and its modulation. Due to fine-specificity differences
between plant and mammalian lectins, even between
those harboring identical monosaccharide specificity, as
seen for example for galactose [Brinck et al., 1998], it is
obvious that monitoring actual capacity for establishing
recognitive interactions in situ is advanced by using
endogenous lectins as test substances.
Staining of sections from normal skin and skin cancers
with carrier-immobilized carbohydrate ligands as well as
biochemical analysis has revealed that receptors for galac-
tosides, especially the already mentioned Gal-3, are
present [Gabius et al., 1990]. Gal-3 expression was de-
tected predominantly in suprabasal layers of squamous
cell epithelia, while its presence is very sparse or lacking in
the basal cell layer and in cells of basal cell cancer of skin
[Konstantinov et al., 1994; Holı´kova´ et al., 1999; Smetana
et al., 1999]. Using labeled Gal-3 as probe, highly differ-
entiated cells of squamous cell carcinomas are positive in
contrast to cells with a low level of differentiation [Del-
orge et al., 2000; Plza´k et al., 2000]. In this system, galec-
tin-1-binding proved to be less selective [Plza´k et al.,
2000]. Furthermore, expression patterns of binding sites
can vary with cellular activity as seen within tumor cells
and during the murine hair cycle [André et al., 1999;
Schwarz et al., 1999; Wollina et al., 2000]. These com-
bined findings raise the interest to employ the mammali-
an galectin as tool to monitor functionally relevant
changes in addition to classical plant lectin histochemis-
try. Concerning functional aspects Gal-3 participates in
cell-extracellular matrix and intercellular interactions and
in macrophage activation following nonclassical secretion
to the extracellular space. It also exerts an antiapoptotic
effect and is involved in pre-mRNA splicing [for review,
see Gabius, 1997, 2001; Kaltner and Stierstorfer, 1998;
Perillo et al., 1998; André et al., 1999; Hughes, 1999;
Smetana et al., 1999; Liu, 2000]. Recent studies further-
more point to functional implication in dendritic cells,
where the Gal-3 transcript belongs to the set of 78 mes-
sages downregulated upon maturation and the protein is
found among the set of proteins related to apoptosis in the
exosomes [Dietz et al., 2000; Théry et al., 2001].
In this study we thus examine the binding of labeled
Gal-3 to human and pig epidermis, human oral mucosa
(tongue) and basal cell carcinoma. In addition, we used
cultured human epidermal cells. Because the plant lectin
Dolichos biflorus agglutinin (DBA) shares binding proper-
ties to the trisaccharide of the A type histoblood group
Gal-3
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antigen with Gal-3, we assessed the binding profile of this
probe. By double labeling, colocalization of lectin-binding
sites with ß1 integrin chain (a potential Gal-3 ligand),
intermediate filaments (cytokeratin 10, CK10), desmoso-
mal proteins (desmoplakin-1, desmoglein) and markers of
proliferation (Ki-67) was evaluated to infer functional
consequences of Gal-3 and DBA binding. With the local-
ization of Gal-3-reactive epitopes in squamous epithelia
differentiation under normal as well as pathological con-
ditions we add complementary information to the listed
reports on immunohistochemical detection of Gal-3.
Material and Methods
Preparation of Tissue and Cell Culture Samples
Samples of collected tissue (table 1) were embedded into Tissue-
Tek (Sakura-Finetek Europe B.V. Zoeterwoude, The Netherlands),
frozen in liquid nitrogen and stored at –70°C prior to further pro-
cessing. Human epidermal cells were cultured according to a pub-
lished procedure in a modified version [Green et al., 1979; Dvorˇa´n-
kova´ et al., 1996] on the surface of coverslips for 48 and 216 h with
lethally irradiated 3T3 mouse fibroblasts as feeders. For refined
monitoring of properties of proliferating keratinocytes a lesion was
deliberately set in 288-hour-old cultures (the cell colonies from the
middle of the covered area were manually removed), and the
Table 1. Number of tissue samples
Tissue Number of donors
Human epidermis (eyelid, chest) 5
Human oral mucosa (base of tongue) 3
Pig1 epidermis 1
Basal cell carcinoma 3
1 Minnesota breed.
‘wounded’ cultures were then processed for analysis 48 h later. Tripli-
cates for each time point were evaluated independently.
Tissue and Cell Processing
The double-labeling procedure with an antibody probe and a sec-
ond lectin probe was previously described [Fronˇkova´ et al., 1999;
Plza´k et al., 2000]. Briefly, 10-Ìm-thin cryostat sections (Cryocut-E,
Reichert, Vienna, Austria) and cultured cells covering coverslips
were washed with phosphate-buffered saline (PBS) and fixed with
2% (w/v) paraformaldehyde for 5 min at room temperature. All spec-
imens were washed 3 times with PBS, and permeabilized with cold
acetone for 5 min. Incubation with a 0.1% solution of bovine serum
albumin (Sigma, Prague, Czech Republic) in PBS was used to block
sites for nonspecific protein-protein interaction. Reactive sites were
visualized using biotinylated Gal-3 [André et al., 1999; Plza´k et al.,
2000] or DBA (Vector Laboratories, Burlingame, Calif., USA) as
probes, both in a concentration of 20 Ìg/ml of incubation solution
(Tris-buffered saline with 10 ÌM of CaCl2 and an antibody diluted as
recommended by the supplier). Lack of influence of the chemical
modification on the properties of Gal-3 was ascertained by solid-
phase assays [André et al., 2000]. Further combinations of lectin and
antibody were tested, as summarized in table 2. FITC-labeled swine
anti-mouse antibodies (USOL, Prague, Czech Republic) and TRITC-
labeled ExtrAvidin (Sigma) were used to visualize the immuno- and
lectin histochemical reactions. Incubation of lectins with lactose and/
or the label-free neoglycoligand containing the trisaccharide of A his-
toblood group antigen served as a competitive control to exclude car-
bohydrate-insensitive binding. Preincubation of specimens with la-
bel-free Gal-3 prior to the incubation step with biotinylated DBA was
employed to illustrate the extent of overlap of binding of both lectins
used. The specificity of immunohistochemical reactions was further
tested by the omission of the first-step antibodies or by their replace-
ment with the antibody anti-CD1a (Immunotech, Prague, Czech
Republic) in the routine procedure. This antibody recognizes Langer-
hans cells in the epidermis only. Any binding to other cells would
indicate a presence of non-antigen-dependent binding sites for the
control monoclonal antibody in the frozen section, a potential for
false-positive data also for the antibodies from the test panel. The
specimens were mounted with Vectashield (Vector Laboratories,
Burlingame) and then examined with a fluorescence microscope (Op-
tiphot-2 equipped with filterblocks for FITC and TRITC fluores-
cence detection). The picture files were stored and the intensity of the
fluorescence signal was quantitated using a computer-assisted image
analysis system (LUCIA) with a CCD camera (Cohu; Laboratory
Imaging, Prague, Czech Republic).
Table 2. Panel of lectins and antibodies
used Lectins Antigens Source of antibody
CK10 Dako, Glostrup, Denmark
DBA Ki-67 nuclear antigen of proliferating cells Immunotech, Prague, Czech Republic
Desmosomal protein desmoplakin-1 Progen, Heidelberg, Germany
Desmosomal protein desmoglein Progen, Heidelberg, Germany
ß1 integrin chain Generous gift of Dr. Fionna
Watt, Keratinocyte Lab.,
Cancer Research Fund, London, UK
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Fig. 1. Expression of Gal-3-binding sites (red signal)
(A–D) and DBA-binding sites (DBA-BS; red signal)
(E–G2) in human epidermis (A, E–G2), human oral
mucosa epithelium – tongue (B, C) and cultured kerati-
nocytes (D). Expression of Ki-67 (A, G1, G2), desmo-
plakin-1 (Dp-1) (B), desmoglein (Dg) (C), ß1 integrin
chain (D, E) and CK10 (F) leads to the green signal.
Colocalization of both signals (red/green) yields yellow
color. Arrows indicate position of basement membrane
(A, F). A limited number of basal cells of human epi-
dermis (b) presented binding sites for both DBA and ß1
integrin chain (E). Ki-67-positive nuclei are marked
with asterisks (G1, G2). Bar = 10 Ìm.
Results
Normal Epithelia in situ
Gal-3 was labeled after recombinant expression with-
out influence on its binding properties. The active prepa-
ration could thus be introduced to the histochemical part
of the investigation as a tool to localize accessible binding
sites for a mammalian lectin. Competitive inhibition
ascertained the activity of the carbohydrate recognition
domain as receptor or as negative modulator of specific
protein-protein interactions by Gal-3. Gal-3-reactive sites
were expressed suprabasally in human and porcine epi-
dermis, the predominant site of Gal-3 expression, as well
as in human oral mucosa. The nuclei of cells binding Gal-
3 were negative for the presence of Ki-67 in specimens of
human origin (fig. 1A). The lack of Gal-3 reactivity in the
basal layer is intriguing. Even if secreted from suprabasal
cells Gal-3 will not function as effector due to the strict
separation of accessible binding sites. In comparison
staining profiles, galectin and immunohistochemistry,
Gal-3-binding sites showed the same distribution pattern
suprabasally as signals for the expression of desmosomal
proteins such as desmoplakin-1 and desmoglein in both
studied human epithelia (fig. 1B, C, table 3). This obser-
vation was corroborated by automatic computer-assisted
analysis of the fluorescence intensity profiles (fig. 2, 3).
The ß1 integrin subunit as present only in the cells located
basally (fig. 1E). However, in this case no colocalization
with binding sites for Gal-3 was observed. Cells with Gal-
3-binding sites shared positivity for CK10 in human and
pig epidermis (table 3).
The variable but mainly weak signal of DBA binding to
the cell surface was observed suprabasally in all studied
types of epithelia. The cells of the basal layer of human
Epidermis (human)
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Fig. 2. Fluorescence intensity measured for four representative inter-
cellular contacts at the level of spinous layer of lingual mucosa. Gal-
3-binding sites and desmoplakin-1 are colocalized.
Fig. 3. Fluorescence intensity measured for three representative
intercellular contacts are the level of spinous layer of lingual mucosa.
Gal-3-binding sites and desmoglein are colocalized.
Table 3. Expression of Gal-3 and DBA-reactive glycoligands and differentiation markers
Tissue Gal-3-BS DBA-BS Ki-67 CK10 ß1 Dp-1 Dg
SBC++
BC–
SBC+/++
BC–/++
SBC–
BC–/++
SBC++
BC–/+
SBC–
BC++
SBC++
BC–/+
SBC++
BC–/+
Epidermis (pig) SBC++
BC–
SBC+
BC–
ND ND ND ND ND
Mucosa (human) SBC++
BC–
SBC+
BC–
SBC–
BC–/++
SBC–
BC–
SBC–
BC+
SBC++
BC–/+
SBC++
BC–/+
Epidermis (cultured) –/++ –/++ –/+/++ –/++ –/+ ND ND
BC carcinoma – –/++ –/++ ND ++ –/++ -/++
Semiquantitative parameters: – = negative; + = weak positivity; ++ = strong positivity. BC = Basal layer cells;
SBC = suprabasal cell layer cells; Gal-3-BS = galectin-3-binding sites; DBA-BS = DBA-binding sites; ß1 = ß1 integrin
chain; Dp-1 = desmoplakin-1; Dg = desmoglein; ND = not determined.
epidermis (not the pig epidermis and human mucosa)
amount to 30–40% of cells strongly positive on the sur-
face. The signal for the expression of the ß1 integrin chain
in these cells was also very intense (fig. 1E). The majority
(90%) of these DBA-positive basal keratinocytes was de-
void of Ki-67 presence in the nuclei. A Ki-67-positive
nucleus was rarely present in a DBA-reactive basal cell
(fig. 1G1). Interestingly, DBA-negative basal cells with
Ki-67-positive nuclei were often located in the vicinity of
a basal DBA-positive cell. Frequently, a cluster of highly
DBA-positive suprabasal cells was seen in the vicinity of a
DBA-negative, Ki-67-positive basal cell (fig. 1G2). Im-
munohistochemically, a so-called normal epidermis close
to basal cell cancer tissue was characterized by conspicu-
ous presence of Ki-67-positive nuclei. The unilateral cyto-
plasmic binding of DBA close to the Ki-67-positive nu-
cleus was commonly observed (not shown).
DBA-positive basal cells generally revealed no clear
indication for the presence of CK10 (fig. 1F). However,
the measurements of the fluorescence intensity showed
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Fig. 4. Measurement of the fluorescence intensity in representative
intercellular contacts in suprabasal layer (spinous layer, SBC) and
basal layer (BC) of human epidermis for expression of CK10 and
binding sites for DBA. Only few basal cell interfaces displayed a
wave-like pattern very similar to that of suprabasal layers (SBC). The
majority of intercellular contacts revealed no signal for the presence
of CK10 (BC1). DBA-BS = DBA-binding sites.
low frequency (up to 10%) of DBA-positive basal cells
expressing a very weak signal for CK10. The DBA-nega-
tive basal cells were completely devoid of these interme-
diate filaments (fig. 4). Basal cell positivity for DBA con-
trasted with lack of binding of Gal-3. Despite sharing a
common aspect within the cellular binding patterns it is
evident that the plant (exogenous) and mammalian (en-
dogenous) lectins differed in individual binding proper-
ties. To further underscore this conclusion, we performed
competition experiments with the two lectins. The prein-
cubation of sections with label-free Gal-3 had no inhibito-
ry effect on the binding of labeled DBA indicating differ-
ent profiles of glycans for these two lectins (not shown). In
order to extend our analysis to tissue culture conditions,
we monitored keratinocytes in culture.
Cultured Epidermis
The Gal-3-binding-site-harboring cultured keratino-
cytes were negative for the expression of ß1 integrin and
Ki-67 (table 3). In small colonies, cells with binding sites
for Gal-3 were located in the center of the respective colo-
ny surrounded by ß1 integrin-positive keratinocytes
(fig. 1D). Up to 20% of ß1 integrin-positive keratinocytes
at the stage of subconfluent or confluent growth were
DBA-reactive circumnuclearly (fig. 5A). Because the Gol-
gi complex represents the central site of glycan chain elab-
oration, this area labeled with DBA could represent places
for GalNAc incorporation. To assess cell features after a
mechanic stimulus, we removed cells from the culture
mimicking a lesion. The ‘wounded’ cultures reacted by
occurrence of proliferating cells, which were devoid of
binding capacity for DBA in the mitotic cells (fig. 5B1).
Similarly, the cells with highly Ki-67-positive nuclei and
compact nucleoli failed to bind DBA (fig. 5B2). The sig-
nificant decrease of the Ki-67-dependent signal in chro-
matin and the presence of ring-shaped nucleoli or micro-
nucleoli were connected with cytoplasmic or cell surface
binding of DBA in the cultured keratinocytes (fig. 5B3,
table 4). Cultured epidermal cells without a Ki-67 signal
in the nuclear region were highly positive for the expres-
sion of DBA-reactive glycoligands (fig. 5B4). CK10 posi-
tivity did not (strictly) correlate with the binding of Gal-3
as well as DBA, because CK10-positive and CK10-nega-
tive cells were recognized by both lectins (fig. 5C, ta-
ble 3).
Basal Cell Carcinoma in situ
No binding of Gal-3 to tumor cells was observed.
Because macrophages as internal positive control reacted
with the labeled galectin, a false-negative result due to
technical problems could be excluded (fig. 5D). DBA
staining of tumor cells had a variable, mosaic-like pattern,
and cells reactive with DBA expressed desmoplakin-1,
desmoglein and the ß1 integrin chain (fig. 5E). Tumor
cells with Ki-67-positive nuclei were characterized by the
absence of DBA reactivity (fig. 5F).
Discussion
Multilayered squamous epithelia are morphologically
stratified tissues with stem cells positioned in the basal
layer. The phenotype of the basal cell layer differs from
that of the suprabasal ones in the expression of several
markers such as cytoskeletal proteins, integrins and cad-
herin receptors. Expression of markers involved in pro-
tein-carbohydrate interaction and sugar-code-dependent
signaling [Villalobo and Gabius, 1998] can also reveal
nonuniform expression. Gal-3 expression with preferen-
tial presence suprabasally and its downregulation in basal
cell carcinoma is an example pointing to relevance of pro-
tein-carbohydrate recognition systems [Konstantinov et
al., 1994; Castronovo et al., 1999; Holı´kova´ et al., 1999].
We therefore examined whether epitope presentation ac-
cessible for Gal-3 is likewise subject to regulation. The
study of Gal-3-specific ligand expression in squamous cell
carcinomas has demonstrated its occurrence in the mark-
Mitotic
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Fig. 5. Detection of DBA-binding sites (DBA-BS;
red signal) (A–C, E, F) and Gal-3-binding sites (red
signal) (D) in cultured keratinocytes (A), ‘wounded’
culture of keratinocytes (B, C) and basal cell carcino-
mas (D–F). Expression of ß1 integrin chain (A, E),
Ki-67 (B1–B4, F), CK10 (C) and desmoplakin-1
(Dp-1) (D) leads to the green signal. Colocalization
of both signals (red/green) yields yellow color. N =
Nucleus (A, B4). Arrows point to nucleoli (B2, B3).
Basal cell carcinoma specimen expressed desmopla-
kin-1 but not Gal-3-BS in contrast to infiltrating leu-
kocytes that served as internal positive control reac-
tion with the biotinylated galectin (D). Positive
blood vessel serves (for DBA-BS) as a control to
exclude false negativity (F). Bar = 10 Ìm.
Table 4. DBA binding to cultured
keratinocytes and its relation to Ki-67
expression and nucleolar morphology
Cells Chromatin Ki-67
FI arbitrary units
Nucleolus Ki-67 DBA-BS
6240 Not present –
Interphasic 122B47 Compact –
66B44 Compact (38%)
Ring-shaped (62%)
Golgi complex
Negative Micronucleoli (13%) Golgi complex
Negative Micronucleoli (5%) Cell surface
FI = Fluorescence intensity; DBA-BS = DBA-binding sites.
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edly differentiated parts of carcinomas in contrast to the
presence of ligands for galectin-1 in these systems [Del-
orge et al., 2000; Plza´k et al., 2000]. The suprabasal
expression of Gal-3-binding sites, observed in the studied
human and pig epithelia, corroborates these observations
and is suggestive of potential auto- and/or paracrine func-
tions of this galectin. Both studied desmosomal proteins
occurred suprabasally and their expression is differentia-
tion-dependent [Kreis and Vale, 1994]. The colocaliza-
tion between Gal-3-binding sites and desmosomal pro-
teins (desmoplakin, desmoglein-1) supports the notion
that these are accessible for Gal-3 at intercellular contacts.
The desmosomes constitute heavily glycosylated intercel-
lular contacts [Cohen et al., 1983; Schaumburg-Lever,
1990] and binding of Gal-3 to this region may, therefore,
concern these contacts. Due to the tendency of Gal-3 to
form multivalent oligomers [Hsu et al., 1992; Ochieng et
al., 1993] it is conceivable that this lectin may participate
in regulating the strength of intercellular contacts of the
suprabasally located cells. The lack of Gal-3 binding to the
ß1 integrin chain, a potential ligand via glycan chains, inti-
mates differentiation- or organ-type-specific differences
in glycosylation. Alternatively, the relevant epitopes
could already be blocked completely in situ by a lectin
masking the glycans. As already mentioned in the intro-
duction, this can well be the case for hensin. Gal-3 is effi-
ciently bundling it for deposition in the matrix, a factor
for induction of terminal differentiation of epithelial cells
[Hikita et al., 2000]. To examine whether a masking
occurs, immunohistochemical colocalization of Gal-3 (or
other galectins with affinity to ß1 integrin glycans) and the
integrin will have to be performed.
In culture, Gal-3-binding cells are negative for ß1 inte-
grin and Ki-67. Both basal cell carcinomas and the basal
cell layer possess no accessible ligands for Gal-3. These
observations, including previous reported findings in oth-
er systems, indicate that the expression of Gal-3 and the
population of its ligands is characterized for the pool of
nonproliferating cells of squamous cell epithelia. Working
with T cell lymphomas and fibroblasts, an antiapoptotic
and proproliferative function of Gal-3 has been detected
[Yang et al., 1996; Inohara et al., 1998]. Moreover, Gal-3
blocks the inhibition of proliferation by galectin-1 in
human SK-N-MC neuroblastoma cells [Kopitz et al.,
2001]. Our results in squamous epithelia suggest that the
role of Gal-3 as proproliferative and antiapoptotic agent
might be cell-type-specific for T lymphocytes, neuroblas-
toma cells and different studied epithelia, because Gal-3
and Gal-3-reactive sites are expressed in the pool of non-
proliferating cells. As shown for cholesteatomas, the pres-
ence of Gal-3 could also contribute to prevent progressive
apoptotic cell loss upon external stimulation [Sheikholes-
lam-Zadeh et al., 2001].
Drawing attention to the binding of the core structure
in addition to substituted ß-galactosides, it can be ex-
plained that the staining profiles with the GalNAc-spe-
cific DBA and Gal-3 did not overlap to a notable extent.
Evidently, substitution of a ß-galactoside by GalNAc will
in this case not produce a frequently encountered set of
shared ligands. With respect to binding of this commonly
used plant lectin, the expression in the epithelium appears
to be species-specific. A weak signal was located on supra-
basal cells in all studied epithelia and on a fraction of bas-
al cells in human epidermis, but not in pig epidermis and
human mucosa. The positivity of basal cells in epidermis
and the signal absence in basal layer of oral mucosa have
been observed previously [Kariniemi and Virtanen, 1989;
Mizukawa et al., 1994]. Our observation of suprabasally
located DBA-positive adds to this body of evidence. The
DBA-positive basal cells express ß1-containing integrins
and they are usually in the vicinity of DBA-negative basal
keratinocytes, which express the Ki-67 antigen. Rarely,
some of these DBA-positive basal cells also express CK10,
which is usually used as a marker of terminally differen-
tiated cells, and CK10 positivity of terminally differen-
tiating basal cells has been reported [Kaur and Li, 2000].
Another interesting feature of our analysis was circum-
nuclear binding of DBA. It was detected in few keratino-
cytes expressing ß1 integrin when cultured to a confluent
monolayer. The stimulation of keratinocyte proliferation
by the removal of cells from the center of the tissue plate
(‘wounded culture’) influenced the phenotype of cultured
keratinocytes concerning DBA binding. No binding of
DBA was observed in the mitotic cells showing intense
Ki-67 staining. Similarly, the interphasic cells with
strongly Ki-67-positive nuclei and prominent Ki-67-posi-
tive compact nucleoli were negative for DBA-binding
sites. The decrease of Ki-67 expression in nuclei and the
conspicuous change of nucleolar morphology from com-
pact to the ring-shaped nucleoli or micronucleoli was con-
nected with circumnuclear expression of DBA-binding
sites. These data suggest that the binding of DBA may be
related to differentiation of epidermal cells and the loss of
their proliferative capacity. The observed changes of the
nucleolar morphology strongly support this hypothesis,
because compact nucleoli are connected with the produc-
tion of rRNA, the ring-shaped nucleoli with the reversible
arrest of production of rRNA and micronucleoli with an
irreversible block of this synthetic line [Busch and Smeta-
na, 1970; Smetana and Broulik, 1994]. In contrast to the
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in situ observation, in vitro experiments showed no rela-
tionship between expression of CK10 and that of Gal-3-
or DBA-binding sites. CK10-positive and CK10-negative
cells were recognized by both lectins.
Basal cell carcinoma cells display a phenotype very
similar to that present in the basal cell layer of a normal
human epidermis. They lack accessible Gal-3-binding
sites and a limited number of cells express DBA-binding
sites (mosaic-like pattern). The basal layer of the normal
epidermis was also negative for the presence of Gal-3-
reactive glycoligands and only few cells in this section
were reactive for DBA.
The glycosylation patterns detected with the endoge-
nous lectin Gal-3 and the plant lectin DBA are a sensitive
phenotypic marker of epidermal cell differentiation, en-
couraging especially further use of endogenous lectins in
the analysis of epithelial tissue with cell biological or
pathological focus. Due to the presence of more than one
type of galectin in various cell types [Gabius et al., 1998;
Lahm et al., 2001], further investigations will have to take
other family members into account.
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